ENZN Enzon Pharmaceuticals Inc

USD 0.09 0.00 -4.761905
Icon

Enzon Pharmaceuticals Inc (ENZN) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.09

0.00 (-4.76)%

USD 5.20M

N/A

N/A

N/A

Icon

ENZN

Enzon Pharmaceuticals Inc (USD)
COMMON STOCK | OTC
USD 0.09
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 5.20M

N/A

USD 0.09

Enzon Pharmaceuticals Inc (ENZN) Stock Forecast

N/A

Based on the Enzon Pharmaceuticals Inc stock forecast from 0 analysts, the average analyst target price for Enzon Pharmaceuticals Inc is not available over the next 12 months. Enzon Pharmaceuticals Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Enzon Pharmaceuticals Inc is Bearish, which is based on 2 positive signals and 5 negative signals. At the last closing, Enzon Pharmaceuticals Inc’s stock price was USD 0.09. Enzon Pharmaceuticals Inc’s stock price has changed by +12.50% over the past week, +28.57% over the past month and -59.09% over the last year.

No recent analyst target price found for Enzon Pharmaceuticals Inc
No recent average analyst rating found for Enzon Pharmaceuticals Inc

Company Overview Enzon Pharmaceuticals Inc

Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Je...Read More

https://www.enzon.com

20 Commerce Drive, Cranford, NJ, United States, 07016

0

December

USD

USA

Adjusted Closing Price for Enzon Pharmaceuticals Inc (ENZN)

Loading...

Unadjusted Closing Price for Enzon Pharmaceuticals Inc (ENZN)

Loading...

Share Trading Volume for Enzon Pharmaceuticals Inc Shares

Loading...

Compare Performance of Enzon Pharmaceuticals Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ENZN

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Enzon Pharmaceuticals Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +0.69 (+0.17%) USD107.38B 29.93 21.06

ETFs Containing ENZN

Symbol Name ENZN's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Enzon Pharmaceuticals Inc (ENZN) Stock

Stock Target Advisor's fundamental analysis for Enzon Pharmaceuticals Inc's stock is Bearish.

Unfortunately we do not have enough data on ENZN's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on ENZN's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on ENZN's stock to indicate if its overvalued.

The last closing price of ENZN's stock was USD 0.09.

The most recent market capitalization for ENZN is USD 5.20M.

Unfortunately we do not have enough analyst data on ENZN's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Enzon Pharmaceuticals Inc's stock.

As per our most recent records Enzon Pharmaceuticals Inc has 0 Employees.

Enzon Pharmaceuticals Inc's registered address is 20 Commerce Drive, Cranford, NJ, United States, 07016. You can get more information about it from Enzon Pharmaceuticals Inc's website at https://www.enzon.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...